5-hydroxymethylcytosine has been researched along with Acute Liver Injury, Drug-Induced in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Feng, F; Li, Y; Ren, Q; Sun, S; Wang, X; Wu, D; Zhang, M; Zhu, H | 1 |
1 other study(ies) available for 5-hydroxymethylcytosine and Acute Liver Injury, Drug-Induced
| Article | Year |
|---|---|
Combined 5-hydroxymethylcytosine content of human leucocyte antigen-B and human leucocyte antigen-DQB1 as novel biomarker for anti-tuberculosis drug-induced liver injury.
Topics: 5-Methylcytosine; Adult; Antitubercular Agents; Biomarkers; Case-Control Studies; Chemical and Drug Induced Liver Injury; DNA Methylation; Female; Genetic Predisposition to Disease; HLA-B Antigens; HLA-DQ beta-Chains; Humans; Male; Middle Aged; Tuberculosis | 2020 |